New insider activity at Edwards Lifesciences ( (EW) ) has taken place on May 23, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Daveen Chopra, CVP of TMTT, has recently sold 1,500 shares of Edwards Lifesciences stock, amounting to a total transaction value of $112,605.
Spark’s Take on EW Stock
According to Spark, TipRanks’ AI Analyst, EW is a Outperform.
Edwards Lifesciences demonstrates strong financial stability with a robust balance sheet and positive cash flow. Positive momentum in technical indicators supports the stock price, but a high P/E ratio suggests limited valuation upside. Recent earnings call highlights growth and strategic progress, though market challenges and tariff impacts pose risks. Corporate event initiatives further support long-term employee engagement.
To see Spark’s full report on EW stock, click here.
More about Edwards Lifesciences
YTD Price Performance: 4.84%
Average Trading Volume: 4,850,933
Technical Sentiment Signal: Buy
Current Market Cap: $45.66B